- Home
- MIST vs ITRG Comparison
MIST vs ITRG Comparison
Compare MIST & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | ITRG |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 482.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MIST | ITRG |
|---|---|---|
| Price | $2.03 | $3.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $8.50 | $4.13 |
| AVG Volume (30 Days) | ★ 10.0M | 1.7M |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $219,125,000.00 |
| Revenue This Year | N/A | $965.93 |
| Revenue Next Year | N/A | $9.39 |
| P/E Ratio | ★ N/A | $51.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $0.79 |
| 52 Week High | $3.06 | $4.69 |
Technical Indicators
Market Signals| Indicator | MIST | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 52.63 |
| Support Level | $1.94 | $3.98 |
| Resistance Level | $2.14 | $4.52 |
| Average True Range (ATR) | 0.31 | 0.24 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 28.97 | 16.27 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.